COVID-19 Vaccine Global Access Is an Urgency
نویسندگان
1 Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran;
doi
10.30476/ijms.2021.47336چکیده
After almost one year of intense global struggle with SARS-CoV-2 since its first report in Dec. 2019, the introduction of several vaccines for COVID-19 prevention has revived hopes in many people around the world. Several vaccines already approved or started to use in different countries are mostly developed based on the spike antigens of SARS-CoV-2, which not only is involved in cell receptor recognition and virulence, but also is very antigenic.
